Interventional Oncology Market Growth and Trends Analysis 2034
Interventional Oncology Market Growth, Size, Trends Analysis - By Technique, By Procedure, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Sep-2025 | Report ID: HLCA25292 | Pages: 1 - 246 | Formats*: |
| Category : Healthcare | |||
Interventional Oncology Market Introduction and Overview
According to SPER Market Research, the Global Interventional Oncology Market is estimated to reach USD 6.77 billion by 2034 with a CAGR of 8.81%.
The report includes an in-depth analysis of the Global Interventional Oncology Market, including market size and trends, product mix, Applications, and supplier analysis. The global interventional oncology market was valued at approximately USD 2.91 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.81% from 2025 to 2034. This expansion is primarily driven by the rising incidence of cancer, advancements in technology for minimally invasive procedures, an increasing elderly population, a heightened emphasis on early cancer detection, and growing investments from both public and private sectors in interventional oncology.
By Technique Insights:
The segment with the highest revenue share in 2024 was ablation therapy. These therapies, including radiofrequency, microwave, cryoablation, and laser ablation, are becoming more popular because they are minimally invasive and effectively target tumors while causing little damage to surrounding tissues. They offer a good alternative to traditional cancer treatments like surgery and radiation, leading to shorter recovery times, less pain, and fewer complications. With rising cancer cases, there is an increasing demand for effective treatment options. The World Health Organization reports that cancer is a leading cause of death worldwide, with expected rises in new cases, which drives interest in ablation therapies.
By Procedure Insights:
The vascular interventions segment also captured a large revenue share in 2024, with procedures like transarterial chemoembolization (TACE), transarterial radioembolization (TARE), and percutaneous transhepatic biliary drainage (PTBD) contributing to its growth. The increase in liver cancer cases and advancements in technology are driving this market. There is a focus on personalized treatment methods, combining these interventions with immunotherapies and improvements in imaging and catheter systems, further aiding growth.
By Application Insights:
The liver cancer segment represented the largest share in 2024, driven by high prevalence rates and the need for effective treatment options. Treatments like RFA, TACE, and microwave ablation are very effective for liver tumors, and outcomes have improved with image-guided procedures. The lung cancer segment is also growing quickly, thanks to advancements in minimally invasive techniques and the high number of lung cancer cases globally.
By End-User Insights:
In hospital settings, the segment accounted for the largest revenue share in 2024, as hospitals can perform interventional oncology procedures such as embolization and ablation. Favorable reimbursement policies for these treatments are also a factor. Conversely, the specialty clinic segment is expected to grow the fastest. The rise in specialty clinics focused on interventional oncology offers personalized care with specialized staff, making them appealing to patients looking for prompt and quality cancer care.
Regional Insights:
The North American interventional oncology market led the global sector in 2024, accounting for the majority of revenue due to a number of factors, including the presence of major market players in the region, significant healthcare spending, increased awareness of minimally invasive procedures, a favourable regulatory environment, and a high cancer prevalence.
The interventional oncology market in the Asia Pacific region is expected to experience the most rapid growth from 2025 to 2034. This anticipated growth is linked to the high cancer rates in the area, the development of healthcare infrastructure, and increasing efforts to promote the adoption of interventional oncology procedures.
Market Competitive Landscape:
Key players in the interventional oncology market are implementing various strategies to enhance their market presence and broaden the reach of their products and services. Initiatives such as expansion and partnerships are crucial in driving market growth. In 2024, Boston Scientific Corporation was the leading company in the interventional oncology market. The company's diverse product range significantly contributes to its market leadership. Additionally, its strong capabilities in research and development, manufacturing, and marketing further bolster its market position.
Recent Developments:
In December 2024, Siemens Healthineers and AP-HP formalized a partnership aimed at innovating healthcare. This agreement fortifies their collaboration in medical imaging, diagnostics, and advanced therapies to enhance patient care and adapt to the evolving landscape of the French healthcare system, with the goal of co-developing new solutions.
In January 2024, Delcath Systems, Inc. announced the inaugural commercial application of HEPZATO KIT for treating metastatic uveal melanoma (mUM). HEPZATO KIT is a combination drug/device product that delivers HEPZATO (melphalan) directly to the liver, providing increased drug exposure in targeted tissues while minimizing systemic toxicity.
In May 2023, IceCure Medical announced that the ProSense System would be installed in Kovai Medical Centre and Hospital in Coimbatore, India. The ProSense System represents a minimally invasive cryoablation technology that eliminates tumors by freezing, serving as an alternative to surgical tumor excision.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Technique, By Procedure, By Application, By End-User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Medtronic plc, Boston Scientific Corporation, Johnson & Johnson (Ethicon), Cook Medical, AngioDynamics Inc, Stryker Corporation, Terumo Corporation, Siemens Healthineers. |
- Global Interventional Oncology Market Size (FY 2021-FY 2034)
- Overview of Global Interventional Oncology Market
- Segmentation of Global Interventional Oncology Market By Technique (Ablation Therapies, Embolization Therapies, Biopsy Techniques, Targeted Therapy Delivery Systems, Image-Guided Procedures)
- Segmentation of Global Interventional Oncology Market By Procedure (Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care)
- Segmentation of Global Interventional Oncology Market By Application (Liver Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Breast Cancer, Other Cancer)
- Segmentation of Global Interventional Oncology Market By End-User (Hospitals, Specialty Clinics, Others)
- Statistical Snap of Global Interventional Oncology Market
- Expansion Analysis of Global Interventional Oncology Market
- Problems and Obstacles in Global Interventional Oncology Market
- Competitive Landscape in the Global Interventional Oncology Market
- Details on Current Investment in Global Interventional Oncology Market
- Competitive Analysis of Global Interventional Oncology Market
- Prominent Players in the Global Interventional Oncology Market
- SWOT Analysis of Global Interventional Oncology Market
- Global Interventional Oncology Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOL’s
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Interventional Oncology Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Interventional Oncology Market
7. Global Interventional Oncology Market, By Technique (USD Million) 2021-2034
- 7.1. Ablation Therapies
- 7.1.1. Radiofrequency Ablation (RFA)
- 7.1.2. Microwave Ablation (MWA)
- 7.1.3. Cryoablation
- 7.1.4. Laser Ablation
- 7.1.5. Irreversible Electroporation (IRE)
- 7.2. Embolization Therapies
- 7.2.1. Transarterial Chemoembolization (TACE)
- 7.2.2. Transarterial Radioembolization (TARE)
- 7.3. Biopsy Techniques
- 7.3.1. Core Needle Biopsy
- 7.3.2. Fine Needle Aspiration (FNA)
- 7.4. Targeted Therapy Delivery Systems
- 7.4.1. Drug-Eluting Beads
- 7.4.2. Radioembolization
- 7.4.3. Drug-Eluting Stents
- 7.4.4. Injectable Hydrogels and Nanoparticles
- 7.4.5. Other Targeted Therapy Systems
- 7.5. Image-Guided Procedures
- 7.5.1. Ultrasound Guidance
- 7.5.2. CT Scan Guidance
- 7.5.3. MRI Guidance
- 7.5.4. Fluoroscopy Guidance
8. Global Interventional Oncology Market, By Procedure (USD Million) 2021-2034
- 8.1. Tumor Ablation
- 8.2. Tumor Biopsy
- 8.3. Vascular Interventions
- 8.4. Palliative Care
9. Global Interventional Oncology Market, By Application (USD Million) 2021-2034
- 9.1. Liver Cancer
- 9.2. Lung Cancer
- 9.3. Kidney Cancer
- 9.4. Prostate Cancer
- 9.5. Breast Cancer
- 9.6. Other Cancer
10. Global Interventional Oncology Market, By End User (USD Million) 2021-2034
- 10.1. Hospitals
- 10.2. Specialty Clinics
- 10.3. Others
11. Global Interventional Oncology Market, (USD Million) 2021-2034
- 11.1. Global Interventional Oncology Market Size and Market Share
12. Global Interventional Oncology Market, By Region, (USD Million) 2021-2034
- 12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
- 12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
- 12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
- 12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
- 12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America
13. Company Profile
- 13.1. Medtronic plc
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. Boston Scientific Corporation
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. Johnson & Johnson (Ethicon)
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. Teleflex Incorporated
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. Cook Medical
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. AngioDynamics Inc
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Stryker Corporation
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Profound Medical
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. Terumo Corporation
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Siemens Healthineers
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
- 13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Interventional Oncology Market is projected to reach USD 6.77 billion by 2034, growing at a CAGR of of 8.81% during the forecast period.
Interventional Oncology Market grew in Market size from 2025. The Market is expected to reach USD 6.77 billion by 2034, at a CAGR of 8.81% during the forecast period.
Interventional Oncology Market CAGR of 8.81% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Interventional Oncology Market size is USD 6.77 billion from 2025 to 2034.
Interventional Oncology Market is covered By Technique, By Procedure, By Application, By End-User
The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Interventional Oncology Market.
Medtronic plc, Boston Scientific Corporation, Johnson & Johnson (Ethicon), Cook Medical, AngioDynamics Inc, Stryker Corporation, Terumo Corporation, Siemens Healthineers.
The report includes an in-depth analysis of the Global Interventional Oncology Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
